Ipsen entered into a strategic partnership with Inspiration Biopharmaceuticals to provide funding to develop the latter’s haemophilia products. Ipsen will also grant Inspiration an exclusive worldwide sublicense to its own recombinant porcine Factor VIII product, OBI-1.